ALL KEYWORDSNeurofibromatosis Type 2, NF2Related SpecialistsShowing 3 of 17Robert MessinaMDAjay MalhotraMBBS, MD, MMMMichele JohnsonMDMore Related SpecialistsRelated Clinical TrialsPhase II Trial of SMO/ AKT/ NF2/CDK Inhibitors in Progressive Meningiomas With SMO/ AKT/ NF2/CDK Pathway MutationsBrain & Other Nervous System Cancers
